This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/uk/527157-uk-novavax-booster-covid19-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| UK preparing for autumn booster shots against Covid-19, says minister, as CureVac fails and Novavax shines in trials | UK preparing for autumn booster shots against Covid-19, says minister, as CureVac fails and Novavax shines in trials |
| (about 2 months later) | |
| The UK health minister has said the government will shortly be announcing its plans for nationwide booster shots against Covid-19 in the autumn, as a trial of different combinations nears its conclusion. | The UK health minister has said the government will shortly be announcing its plans for nationwide booster shots against Covid-19 in the autumn, as a trial of different combinations nears its conclusion. |
| Speaking to BBC Breakfast on Monday, Health Secretary Matt Hancock said the authorities were currently trialing a number of vaccine combinations that could boost Britons’ immunity against the novel coronavirus and its many variants. | Speaking to BBC Breakfast on Monday, Health Secretary Matt Hancock said the authorities were currently trialing a number of vaccine combinations that could boost Britons’ immunity against the novel coronavirus and its many variants. |
| “In the next few weeks, when we get the clinical data through on what’s the most effective combinations to have … then we’ll set out all the details for the booster programme for the autumn,” Hancock stated. | “In the next few weeks, when we get the clinical data through on what’s the most effective combinations to have … then we’ll set out all the details for the booster programme for the autumn,” Hancock stated. |
| The UK’s Cov-Boost trial, which tests a variety of vaccine combos, has become increasingly relevant, given the current prevalence of the Indian virus variant, known as Delta. | The UK’s Cov-Boost trial, which tests a variety of vaccine combos, has become increasingly relevant, given the current prevalence of the Indian virus variant, known as Delta. |
| Scientists, including Dr Susan Hopkins, strategic response director for Covid-19 at Public Health England, have warned of the prospect of further lockdowns later in the year. “I can’t predict the future – it really depends on whether the hospitals start to become overwhelmed at some point,” Hopkins told the BBC’s Andrew Marr. | Scientists, including Dr Susan Hopkins, strategic response director for Covid-19 at Public Health England, have warned of the prospect of further lockdowns later in the year. “I can’t predict the future – it really depends on whether the hospitals start to become overwhelmed at some point,” Hopkins told the BBC’s Andrew Marr. |
| On Sunday, the day before the UK’s lockdown was originally scheduled to end, the country registered 9,284 Covid-19 cases, many of which are the Delta variant. | On Sunday, the day before the UK’s lockdown was originally scheduled to end, the country registered 9,284 Covid-19 cases, many of which are the Delta variant. |
| The UK had hoped that CureVac, a German biotech firm, would provide a booster jab for the country this autumn. However, last week, the company’s trial revealed that its vaccine was only 47% effective. | The UK had hoped that CureVac, a German biotech firm, would provide a booster jab for the country this autumn. However, last week, the company’s trial revealed that its vaccine was only 47% effective. |
| Meanwhile, US firm Novavax published extremely positive trial data last week, with its vaccine proving more than 90% effective against a variety of virus variants. The jab will be produced in the UK, if granted approval. | Meanwhile, US firm Novavax published extremely positive trial data last week, with its vaccine proving more than 90% effective against a variety of virus variants. The jab will be produced in the UK, if granted approval. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |